Charles Janac, president and CEO of Arteris, Inc. (NASDAQ:AIP), executed insider sales totaling $375,438 across two dates in early April.
On April 2, Janac sold 9,009 shares of Arteris common stock in several transactions at a price of $17.6528 per share, generating proceeds of $159,034. Those sales were carried out to meet tax liabilities associated with the release of restricted stock units.
Four days later, on April 6, Janac sold an additional 11,800 shares. The April 6 dispositions were executed at prices ranging from $18.20 to $18.63, producing a weighted average price of $18.3394 and total proceeds of $216,404. Janac made the April 6 sale pursuant to a pre-established Rule 10b5-1 trading plan that he adopted on March 5, 2025.
After these transactions, Janac's direct ownership in Arteris stands at 196,729 shares of common stock. He also holds indirect interests amounting to 9,189,071 shares through Bayview Legacy, LLC, and 56,252 shares through the Charles and Lydia Janac Trust.
The insider sales occurred against a backdrop of significant share-price appreciation for Arteris. The stock has risen 205% over the past year and gained 22% in the most recent week. The company is currently valued at a market capitalization of $827.5 million.
Investor-oriented analysis from InvestingPro flagged Arteris as appearing overvalued at current levels. The commentary suggested that deeper valuation and growth analysis is available through a comprehensive Pro Research Report covering this and other U.S. equities.
Separately, Arteris reported fourth-quarter 2025 results that exceeded consensus estimates on both revenue and earnings per share. The company recorded revenue of $20.1 million, ahead of the projected $18.55 million, and reported EPS of negative $0.05 versus an expected negative $0.07. Those results were noted as outperforming forecasts and were highlighted in discussions of the company's recent financial performance.
Context and implications
The April 2 trades were explicitly tied to tax withholding obligations arising from RSU vesting. The April 6 sale was executed under a prearranged 10b5-1 plan adopted March 5, 2025. Beyond the mechanics of these specific sales, the transactions were recorded as insider activity while the share price has seen a marked increase year-over-year.